Literature DB >> 21247847

Panhypopituitarism secondary to a macroprolactinoma manifesting with pancytopenia: case report and literature review.

George I Holmes1, Pat Shepherd, James D Walker.   

Abstract

OBJECTIVE: To present a case of pancytopenia associated with hypopituitarism secondary to a macroprolactinoma.
METHODS: We report the clinical features on presentation and results of laboratory investigation. Findings on magnetic resonance imaging are illustrated. The response to hormone replacement therapy is summarized.
RESULTS: A 46-year-old man was referred with pancytopenia and secondary hypothyroidism. Laboratory investigation revealed hypopituitarism and a substantially increased prolactin level. Magnetic resonance imaging of the head demonstrated a macroprolactinoma. Hematologic investigation disclosed no other cause for the pancytopenia. Hormone replacement therapy was initiated with hydrocortisone, levothyroxine, and testosterone. Cabergoline was used to induce regression of the prolactinoma. A rapid improvement was seen in the cytopenias, with normalization of the blood cell counts after 8 months of treatment. This result has been sustained during 29 months of follow-up.
CONCLUSION: Pancytopenia associated with hypopituitarism has been reported in the literature as a rare occurrence limited to isolated case reports, predominantly associated with Sheehan syndrome. To our knowledge, this is the first reported case of pancytopenia associated with a macroprolactinoma. This finding is noteworthy because prolactin alone has been reported to support hematopoiesis in animal studies.

Entities:  

Mesh:

Year:  2011        PMID: 21247847     DOI: 10.4158/EP10298.CR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  2 in total

Review 1.  Hormones and the bone marrow: panhypopituitarism and pancytopenia in a man with a pituitary adenoma.

Authors:  Dianna Lang; Jennifer S Mead; David B Sykes
Journal:  J Gen Intern Med       Date:  2015-05       Impact factor: 5.128

2.  Lack of TSH stimulation in patients with differentiated thyroid cancer - possible causes.

Authors:  Paweł Gut; Magdalena Matysiak-Grześ; Jakub Fischbach; Aleksandra Klimowicz; Maria Gryczyńska; Marek Ruchała
Journal:  Contemp Oncol (Pozn)       Date:  2012-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.